NewAmsterdam Pharma Co N.V annual operating expenses
2021
2022
2023
2024
2025
NewAmsterdam Pharma Co N.V Operating Expenses Growth & History (NAMS)
NewAmsterdam Pharma Co N.V's operating expenses was $248.2M for fiscal 2025.
View full NewAmsterdam Pharma Co N.V company overviewNewAmsterdam Pharma Co N.V annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $248.2M | $26.3M | +11.87% |
| 2024 | 2024-12-31 | $221.9M | $24.8M | +12.58% |
| 2023 | 2023-12-31 | $197.1M | $90.8M | +85.46% |
| 2022 | 2022-12-31 | $106.3M | $71.3M | +203.77% |
| 2021 | 2021-12-31 | $35.0M | — | — |
NewAmsterdam Pharma Co N.V quarterly operating expenses
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $68.6M | $13.8M | +25.16% |
| Q1 2026 | 2026-03-31 | $61.5M | −$10.4M | −14.52% |
| Q4 2025 | 2025-12-31 | $66.0M | $10.0M | +17.88% |
| Q3 2025 | 2025-09-30 | $55.5M | $1.4M | +2.54% |
| Q2 2025 | 2025-06-30 | $54.8M | −$74,000 | −0.13% |
| Q1 2025 | 2025-03-31 | $71.9M | $15.0M | +26.41% |
| Q4 2024 | 2024-12-31 | $56.0M | $4.1M | +7.95% |
| Q3 2024 | 2024-09-30 | $54.1M | $1.6M | +3.08% |
| Q2 2024 | 2024-06-30 | $54.9M | $10.7M | +24.11% |
| Q1 2024 | 2024-03-31 | $56.9M | $8.4M | +17.33% |
| Q4 2023 | 2023-12-31 | $51.9M | — | — |
| Q3 2023 | 2023-09-30 | $52.5M | — | — |
| Q2 2023 | 2023-06-30 | $44.2M | — | — |
| Q1 2023 | 2023-03-31 | $48.5M | — | — |
NewAmsterdam Pharma Co N.V operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, NewAmsterdam Pharma Co N.V's operating expenses increased from $35.0M to $248.2M, a change of $213.2M. The latest reported quarter, Q2 2026, shows $68.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewAmsterdam Pharma Co N.V source filings ↗